S2Medical AB (publ) signs a distribution agreement for the Iranian market
S2Medical AB (publ) has signed a distribution agreement for the Iranian market with Avije Teb Parsin. The agreement covers the company's skin substitute Epiprotect and involves initial orders of a total of approximately SEK 740,000 as well as obligations for further orders of approximately SEK 10.6 million up to and including 2026. The initial order is subject to registration of the product and is expected to be shipped in approximately 6 months. Iran, with its almost 90 million inhabitants, is one of the region's most populous countries. In 2019, there were 15 specialized burn